Read our recent press:
Pensions and Investments: Cardinal Health to disclose financial risks of opioid crisis; shareholder proposal withdrawn
STAT News: Under pressure from investors, Cardinal Helath agrees to bolster opioid oversight
Financial Times: Pharma investors mobilize on reputational risk concerns
Stat News: AmerisourceBergen shareholders reject proposal on managing opioid risks
Evening Standard: Aberdeen, Schroders and Hermes question US pharma giants over opioid abuse
Illinois Times: The pill pipeline: H.D. Smith under fire for opioid sales
Reuters: Investor group presses U.S. drug companies on opioid controls
London Evening Standard: Aberdeen, Schroders and Hermes question US pharma giants over opioid abuse
Stat News: Advisory firms back proposals requiring AmerisourceBergen to manage opioid risks
SNL: Catholic fund leads charge for stronger opioid controls at drugmakers, distributors
Press Releases:
Investors for Opioid Accountability/ IOA on Cardinal Health Annual Shareholder Meeting
$1.3 Trillion Investor Coalition Probes Pharma on Opioid Accountability